Drug Clinical Trials List

Study Title	Study Sponsor	Status	Study Drug	Trial Phase	Study Protocol Number	Site
Adjunct Low Dose Ketamine Infusion Versus Standard of Care in Mechanically Ventilated Critically Ill Patients at a Tertiary Saudi Hospital (ATTAINMENT Trial): Randomized, Prospective, Pilot Trial	King Faisal Specialist Hospital and Research Centre	Ongoing	Ketamine	3	2191187	KFSH & RC-R
A two part seamless, open label, multi-center study to investigate the safety, tolerability, pharmacokinetics, pharmacodynamics and efficacy of RO7034067 in infants with type 1 spinal muscular atrophy.	Roche	Ongoing	RO7034067	2	BP39056	KFSH&RC-R
A Trial of Favipiravir in Adults with Mild Coronavirus Disease Covid-19	KAIMRC	Ongoing	Favipiravir	3	RC20/220/R	NGHA-R
A Trial of Favipiravir and Hydroxychloroquine combination in Adults Hospitalized with moderate and severe Covid-19	KAIMRC	Terminated	Favipiravir	3	RC20/174/R	NGHA-R
A three-arm, randomized, open-label, phase II study of everolimus in combination with exemestane versus everolimus alone versus capecitabine in the treatment of postmenupausal women with estrogen receptor postive, locally advanced, recurrent or metastatic breast cancer after recurrence or progression on prior letrozole or anastrozole.	Novartis	Rejected	Everolimus + Exemestane VS. Everolimus VS. Capecitabine	2	CRAD001Y2201	KFSH & RC-R
A single-arm, prospective, multicentre, open-label study to evaluate ofatumumab treatment effectiveness and patient reported outcomes in patients with relapsing multiple sclerosis transitioning from dimethyl fumarate or fingolimod therapy	Novartis	Ongoing	Ofatumumab	3b	COMB157G23101	King Faisal Specialist Hospital and Research Center (Jeddah)
A SINGLE-ARM, MULTICENTER PHASE IIIB CLINICAL TRIAL TO EVALUATE THE SAFETY AND TOLERABILITY OF PROPHYLACTIC EMICIZUMAB IN HEMOPHILIA A PATIENTS WITH INHIBITORS	Roche	Completed	Emicizumab	3	MO39129	KFSH & RC-R
A Randomized, Open-Label, Phase 3 Study of Abemaciclib combined with Standard Adjuvant Endocrine Therapy versus Standard Endocrine Therapy Alone in Patients with High Risk Node Positive Early Stage Hormone Receptor Positive, Human Epidermal Receptor 2 Negative Breast Cancer	Eli Lilly	Ongoing	abemaciclib	3	I3Y-MC-JPCF	KFMC
A Randomized, Open-label, Multicentral, Two Arm, Phase II Study to Investigate the Benefits of an Improved Deferasirox Formulation (Film-coated Tablet)	Novartis	Completed	Deferasirox dispersible tablet / Defearisox film-coated tablet	2	CICL670F2201	KKUH
A Randomized, Open-label Trial of Paritaprevir Plus Ritonavir Plus Ombitasvir in the Treatment of HCV Genotype 4 Infected Patients with Stage 4-5 Chronic Kidney Disease	Abbvie Biopharmaceuticals GmbH / KSU Liver Disease Research Center	Ongoing	ombitasvir \ paritaprevir \ ritonavir	3	Version 1.3.1	NGHA-J